Felicia Seemann1,2, Per Arvidsson1, David Nordlund1, Sascha Kopic1, Marcus Carlsson1, Håkan Arheden1, Einar Heiberg1,2,3. 1. Department of Clinical Physiology, Lund University, Skåne University Hospital (F.S., P.A., D.N., S.K., M.C., H.A., E.H.). 2. Department of Biomedical Engineering (F.S., E.H.), Lund University, Sweden. 3. Wallenberg Center for Molecular Medicine (E.H.), Lund University, Sweden.
Abstract
BACKGROUND: Pressure-volume (PV) loops provide a wealth of information on cardiac function but are not readily available in clinical routine or in clinical trials. This study aimed to develop and validate a noninvasive method to compute individualized left ventricular PV loops. METHODS: The proposed method is based on time-varying elastance, with experimentally optimized model parameters from a training set (n=5 pigs), yielding individualized PV loops. Model inputs are left ventricular volume curves from cardiovascular magnetic resonance imaging and brachial pressure. The method was experimentally validated in a separate set (n=9 pig experiments) using invasive pressure measurements and cardiovascular magnetic resonance images and subsequently applied to human healthy controls (n=13) and patients with heart failure (n=28). RESULTS: There was a moderate-to-excellent agreement between in vivo-measured and model-calculated stroke work (intraclass correlation coefficient, 0.93; bias, -0.02±0.03 J), mechanical potential energy (intraclass correlation coefficient, 0.57; bias, -0.04±0.03 J), and ventricular efficiency (intraclass correlation coefficient, 0.84; bias, 3.5±2.1%). The model yielded lower ventricular efficiency ( P<0.0001) and contractility ( P<0.0001) in patients with heart failure compared with controls, as well as a higher potential energy ( P<0.0001) and energy per ejected volume ( P<0.0001). Furthermore, the model produced realistic values of stroke work and physiologically representative PV loops. CONCLUSIONS: We have developed the first experimentally validated, noninvasive method to compute left ventricular PV loops and associated quantitative measures. The proposed method shows significant agreement with in vivo-derived measurements and could support clinical decision-making and provide surrogate end points in clinical heart failure trials.
BACKGROUND: Pressure-volume (PV) loops provide a wealth of information on cardiac function but are not readily available in clinical routine or in clinical trials. This study aimed to develop and validate a noninvasive method to compute individualized left ventricular PV loops. METHODS: The proposed method is based on time-varying elastance, with experimentally optimized model parameters from a training set (n=5 pigs), yielding individualized PV loops. Model inputs are left ventricular volume curves from cardiovascular magnetic resonance imaging and brachial pressure. The method was experimentally validated in a separate set (n=9 pig experiments) using invasive pressure measurements and cardiovascular magnetic resonance images and subsequently applied to human healthy controls (n=13) and patients with heart failure (n=28). RESULTS: There was a moderate-to-excellent agreement between in vivo-measured and model-calculated stroke work (intraclass correlation coefficient, 0.93; bias, -0.02±0.03 J), mechanical potential energy (intraclass correlation coefficient, 0.57; bias, -0.04±0.03 J), and ventricular efficiency (intraclass correlation coefficient, 0.84; bias, 3.5±2.1%). The model yielded lower ventricular efficiency ( P<0.0001) and contractility ( P<0.0001) in patients with heart failure compared with controls, as well as a higher potential energy ( P<0.0001) and energy per ejected volume ( P<0.0001). Furthermore, the model produced realistic values of stroke work and physiologically representative PV loops. CONCLUSIONS: We have developed the first experimentally validated, noninvasive method to compute left ventricular PV loops and associated quantitative measures. The proposed method shows significant agreement with in vivo-derived measurements and could support clinical decision-making and provide surrogate end points in clinical heart failure trials.
Entities:
Keywords:
bias; biomarkers; heart failure; humans; magnetic resonance imaging
Authors: A Faragli; R Tanacli; C Kolp; D Abawi; T Lapinskas; C Stehning; B Schnackenburg; F P Lo Muzio; L Fassina; B Pieske; E Nagel; H Post; S Kelle; A Alogna Journal: J Cardiovasc Magn Reson Date: 2020-11-30 Impact factor: 5.364
Authors: Felix Sebastian Oberhoffer; Pengzhu Li; André Jakob; Robert Dalla-Pozza; Nikolaus Alexander Haas; Guido Mandilaras Journal: Sensors (Basel) Date: 2022-09-23 Impact factor: 3.847
Authors: Hannah V Meyer; Timothy J W Dawes; Marta Serrani; Wenjia Bai; Paweł Tokarczuk; Jiashen Cai; Antonio de Marvao; Albert Henry; R Thomas Lumbers; Jakob Gierten; Thomas Thumberger; Joachim Wittbrodt; James S Ware; Daniel Rueckert; Paul M Matthews; Sanjay K Prasad; Maria L Costantino; Stuart A Cook; Ewan Birney; Declan P O'Regan Journal: Nature Date: 2020-08-19 Impact factor: 49.962
Authors: Melissa Baiocchi; Shirley Barsoum; Seyedvahid Khodaei; Jose M de la Torre Hernandez; Sydney E Valentino; Emily C Dunford; Maureen J MacDonald; Zahra Keshavarz-Motamed Journal: Front Bioeng Biotechnol Date: 2021-07-08
Authors: Felicia Seemann; Jonathan Berg; Kristian Solem; Robert Jablonowski; Håkan Arheden; Marcus Carlsson; Einar Heiberg Journal: J Appl Physiol (1985) Date: 2020-08-20